Prognostic variables in node-negative and node-positive breast cancer

activity adjuvant therapy analysis angiogenesis antibody antigen assay associated axillary lymph node Biol biological breast cancer breast cancer cells breast cancer patients Breast Cancer Res breast carcinoma c-erbB2 Cancer Res Treat cell cycle cell lines chemotherapy Clin Oncol clinical correlation cutpoints cyclin D1 cyclin E detected disease disease-free survival endothelial estrogen receptor evaluated expression follow-up gene grade growth factor receptor hazard ratio HER2/neu histologic hormonal therapy human breast cancer IGF1R immunohistochemical inhibitor kinase laminin lesions levels ligand mammary matrix metalloproteinase metalloproteinase metastasis metastatic metastatic breast cancer microvessel count Natl Cancer Inst negative node-negative node-negative breast cancer node-positive Oncogene outcome overall survival overexpression Pathol ploidy predictive factors primary breast cancer prognostic factors prognostic markers prognostic significance prognostic value proliferation protein recurrence relapse response risk S-phase fraction studies surgery tamoxifen tissue treatment tumor cells tumor markers variables vascular